DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Spironolactone (Spironolactone) - Dyspnoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dyspnoea (42)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Spironolactone where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 42   Next >>

Possible Spironolactone side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-24

Patient: male

Reactions: Malaise, Dyspnoea, Hyperkalaemia, Hypotension, Bradycardia, Renal Failure Chronic

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Atacand
    Dosage: 8 mg
    Administration route: Oral
    Indication: Hypertensive Heart Disease
    End date: 2012-06-21

Nebivolol
    Dosage: 2.5 mg
    Administration route: Oral
    Indication: Hypertensive Heart Disease
    End date: 2012-06-21

Spironolactone
    Dosage: 25 mg
    Administration route: Oral
    Indication: Hypertensive Heart Disease
    End date: 2012-06-21

Other drugs received by patient: Aspirin; VI-DE 3; Calcimagon D3; Torsemide; Lantus; Allopurinol; Atorvastatin Calcium; Humalog; Marcumar



Possible Spironolactone side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-23

Patient: 62 year old male

Reactions: Emphysema, Metabolic Alkalosis, Dyspnoea, Glomerular Filtration Rate Decreased, Renin Increased, Drug Abuse, Electrolyte Depletion, Hypokalaemia, Respiratory Acidosis, Ventricular Tachycardia, Oedema, Hyperaldosteronism, Hypertension, Alkalosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Dosage: 50 mg, per day
    Indication: Hypertension

Furosemide
    Dosage: 40 mg, per day
    Indication: Oedema Peripheral

Perindopril
    Dosage: 4 mg, per day
    Indication: Hypertension

Licorice
    Dosage: 300 mg, daily
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Tiotropium; Salmeterol; Fluticasone



Possible Spironolactone side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-15

Patient: female

Reactions: Vomiting, Dyspnoea, Extrasystoles, Hyperhidrosis, Tremor, Suicidal Ideation, Dysgeusia, Fatigue, Palpitations, Feeling Hot, Heart Rate Increased, Asthenia

Drug(s) suspected as cause:
Sotalol HCL
    Dosage: sotalol 80 mg in the morning as well as 40 mg of sotalol in the evening
    Administration route: Oral

Spironolactone
    Administration route: Oral

Multaq
    Dosage: 10am and 10pm.
    Administration route: Oral
    Indication: Atrial Fibrillation

Other drugs received by patient: Actonel; Aspirin



Possible Spironolactone side effects in male

Reported by a physician from France on 2012-06-20

Patient: male

Reactions: Blood Pressure Increased, Agitation, Fluid Overload, Dyspnoea, Hyperkalaemia, Pulmonary Arterial Hypertension, Nodal Rhythm, General Physical Health Deterioration, Anxiety, Retrograde P-Waves, Hypophagia, Bradycardia, Asthenia, Sinus Arrhythmia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tarka
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-03

Spironolactone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-04-03

Altizide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-04-03

Other drugs received by patient: Metformin HCL; Voltaren; Spiriva; Vastarel (Trimetazidine); Omeprazole; Prazepam; Hyperium (Rilmenidine); Ixprim (Tramadol / Paracetamol)



Possible Spironolactone side effects in male

Reported by a physician from France on 2012-06-20

Patient: male

Reactions: Fluid Overload, Agitation, Blood Pressure Increased, Dyspnoea, Hyperkalaemia, Pulmonary Arterial Hypertension, General Physical Health Deterioration, Nodal Rhythm, Anxiety, Retrograde P-Waves, Hypophagia, Bradycardia, Asthenia, Sinus Arrhythmia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-04-03

Tarka
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-03

Altizide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-04-03

Other drugs received by patient: Voltaren; Vastarel (Trimetazidine); Hyperium (Rilmenidine); Metformin HCL; Ixprim (Tramadol / Paracetamol); Spiriva; Prazepam; Omeprazole



Possible Spironolactone side effects in 87 year old female

Reported by a consumer/non-health professional from United States on 2012-06-07

Patient: 87 year old female, weighing 59.0 kg (129.7 pounds)

Reactions: Weight Increased, Dyspnoea, Swelling, Fear

Drug(s) suspected as cause:
Spironolactone



Possible Spironolactone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-23

Patient: 49 year old male

Reactions: Myalgia, Dyspnoea

Drug(s) suspected as cause:
Amlodipine Besylate and Olmesartan Medoxomil
    Dosage: 5/20 mg
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-04
    End date: 2011-07-11

Spironolactone
    Dosage: 25 mg, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-04
    End date: 2011-07-11

Other drugs received by patient: Furosemide



Possible Spironolactone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-23

Patient: 49 year old male

Reactions: Myalgia, Dyspnoea

Drug(s) suspected as cause:
Sevikar (Olmesartan Medoxomil, Amlodipine Besilate) (Tablet) (Olmesart
    Dosage: (1 in 1 d), per oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-04
    End date: 2011-07-11

Spironolactone
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Furosemide



Possible Spironolactone side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from China on 2012-05-15

Patient: 65 year old female

Reactions: Productive Cough, Vomiting, Dyspnoea, Nausea, Mental Status Changes, Condition Aggravated, Toxicity To Various Agents, Poor Quality Sleep, Anxiety, Malaise, Blood Potassium Decreased, Psychiatric Symptom, Chest Pain, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Digoxin
    Administration route: Oral
    Start date: 2008-05-01
    End date: 2010-07-01

Furosemide

Digoxin
    Administration route: Oral
    Start date: 2010-07-01
    End date: 2010-09-29

Spironolactone

Digoxin
    Administration route: Oral
    Start date: 2010-10-08



Possible Spironolactone side effects in 75 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-04-25

Patient: 75 year old female

Reactions: Metabolic Acidosis, Dyspnoea, Hypoventilation, Hyperkalaemia, Bundle Branch Block Left, Atrial Fibrillation, Muscular Weakness, Oedema Peripheral, Oliguria, Tachypnoea, Bradycardia, Blood Creatinine Increased, Blood Pressure Decreased, Cardiac Failure Congestive, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Irbesartan + Hydrochlorothiazide

Fluvastatin

Nebivolol
    Dosage: 5 mg/day

Spironolactone
    Dosage: 100 mg/day



Possible Spironolactone side effects in 75 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-04-25

Patient: 75 year old female

Reactions: Hypoventilation, Dyspnoea, Metabolic Acidosis, Hyperkalaemia, Atrial Fibrillation, Bundle Branch Block Left, Muscular Weakness, Oedema Peripheral, Oliguria, Tachypnoea, Bradycardia, Blood Pressure Decreased, Blood Creatinine Increased, Renal Failure Acute, Cardiac Failure Congestive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fluvastatin

Nebivolol
    Dosage: 5 mg/day

Irbesartan and Hydrochlorothiazide

Spironolactone
    Dosage: 100 mg/day



Possible Spironolactone side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-24

Patient: 60 year old male, weighing 94.4 kg (207.7 pounds)

Reactions: Dyspnoea, Palpitations, International Normalised Ratio Decreased, Drug Interaction

Drug(s) suspected as cause:
Bumetanide

Spironolactone

Other drugs received by patient possibly interacting with the suspect drug:
Victoza
    Dosage: unk
    Start date: 2011-10-17
    End date: 2012-01-18

Warfarin Sodium

Other drugs received by patient: Bisoprolol Fumarate; Metformin HCL; Omeprazole; Atorvastatin; Candesartan Cilexetil



Possible Spironolactone side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-23

Patient: 71 year old female, weighing 84.5 kg (185.9 pounds)

Reactions: Dyspnoea, Stress Cardiomyopathy, Renal Failure Acute, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bumetanide
    Indication: Prophylaxis

Spironolactone
    Indication: Prophylaxis

Ramipril
    Indication: Prophylaxis

Other drugs received by patient: Atenolol and Chlorthalidone; Atenolol and Chlorthalidone; Aspirin



Possible Spironolactone side effects in male

Reported by a physician from United States on 2012-04-16

Patient: male, weighing 127.4 kg (280.4 pounds)

Reactions: Emphysema, Death, Renal Disorder, Dyspnoea, Diarrhoea, Blood Potassium Increased, Blood Creatinine Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Lasix
    Dosage: 40 mg, tid
    Administration route: Oral
    Indication: Hypertension

Lasix
    Indication: Oedema

Gleevec
    Dosage: 400 mg, daily
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    Start date: 2010-08-31

Spironolactone
    Dosage: 25 mg, daily
    Administration route: Oral
    Indication: Hypertension

Spironolactone
    Indication: Oedema

Other drugs received by patient: Advair Diskus 100 / 50; Potassium Chloride; Singulair; Triamterene; Synthroid; Doxycycline; Hydrochlorothiazide; Prednisone TAB; Atenolol; Proair (Fluticasone Propionate); Prevacid; Theophylline



Possible Spironolactone side effects in male

Reported by a physician from United States on 2012-04-16

Patient: male, weighing 127.4 kg (280.4 pounds)

Reactions: Death, Emphysema, Renal Disorder, Dyspnoea, Diarrhoea, Blood Potassium Increased, Blood Creatinine Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Spironolactone
    Indication: Oedema

Gleevec
    Dosage: 400 mg, daily
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    Start date: 2010-08-31

Lasix
    Dosage: 40 mg, tid
    Administration route: Oral
    Indication: Hypertension

Spironolactone
    Dosage: 25 mg, daily
    Administration route: Oral
    Indication: Hypertension

Lasix
    Indication: Oedema

Other drugs received by patient: Prednisone TAB; Prevacid; Hydrochlorothiazide; Potassium Chloride; Atenolol; Triamterene; Theophylline; Singulair; Doxycycline; Advair Diskus 100 / 50; Proair (Fluticasone Propionate); Synthroid



Possible Spironolactone side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-16

Patient: female

Reactions: Blood Pressure Increased, Dyspnoea, Drug Ineffective, Rhinorrhoea, Headache, Oropharyngeal Pain, Somnolence, Abdominal Pain Upper, Fatigue, Malaise, Activities of Daily Living Impaired, Diarrhoea, DRY Throat, Dizziness, Cough

Drug(s) suspected as cause:
Ramipril

Valturna
    Dosage: 1 df, per day

Clonidine
    Dosage: 3 df, per day

Spironolactone
    Dosage: 25 mg

Norvasc

Diovan

Other drugs received by patient: Cymbalta; Aspirin; Lantus; Hydrochlorothiazide; Metfformin Hydrochloride; Lopressor; Glimepiride



Possible Spironolactone side effects in 85 year old male

Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-04-03

Patient: 85 year old male

Reactions: Fatigue, Dyspnoea, Dehydration, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torsemide
    Dosage: 40;20 mg (40 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Cardiac Disorder
    Start date: 2012-01-01

Torsemide
    Dosage: 40;20 mg (40 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Cardiac Disorder
    Start date: 2012-01-02
    End date: 2012-01-02

Warfarin Sodium
    End date: 2012-01-02

Spironolactone
    Dosage: 12 mg (12 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Cardiac Disorder
    End date: 2012-01-02

Other drugs received by patient: Enalapril Maleate; Simvastatin; Selokenzoc (Metoprolol Succinate); Imdur; Panocod (Paracetamol, Codeine Phosphate Hemihydrate); Acetaminophen; Mollepect (Bromphexinhydrochloride, Ephedrinehydrochloride)



Possible Spironolactone side effects in 42 year old female

Reported by a consumer/non-health professional from United States on 2012-03-26

Patient: 42 year old female, weighing 133.4 kg (293.4 pounds)

Reactions: Dyspnoea, Hypoaesthesia, Paraesthesia

Drug(s) suspected as cause:
Spironolactone



Possible Spironolactone side effects in male

Reported by a physician from Germany on 2012-03-14

Patient: male, weighing 95.0 kg (209.0 pounds)

Reactions: Blood Pressure Increased, Left Ventricular Dysfunction, Dyspnoea, Angina Pectoris, Congestive Cardiomyopathy, Bundle Branch Block Left, Atrioventricular Block, Obstructive Airways Disorder

Drug(s) suspected as cause:
Torsemide
    Dosage: 20 meq/kg, qd
    Administration route: Oral
    Start date: 2011-10-31

Rasilez
    Dosage: 300 mg, qd
    Administration route: Oral

Bisoprolol Fumarate
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Start date: 2011-10-31

Omeprazole
    Dosage: 20 mg, qd
    Administration route: Oral
    Start date: 2011-10-31

Metformin HCL
    Dosage: 2000 mg, qd
    Administration route: Oral
    Start date: 2011-10-31

Spironolactone
    Dosage: 25 mg, qd
    Administration route: Oral
    Start date: 2011-10-31

Other drugs received by patient: Oral Antidiabetics



Possible Spironolactone side effects in male

Reported by a physician from Germany on 2012-03-14

Patient: male, weighing 95.0 kg (209.0 pounds)

Reactions: Blood Pressure Increased, Left Ventricular Dysfunction, Dyspnoea, Angina Pectoris, Atrioventricular Block, Bundle Branch Block Left, Congestive Cardiomyopathy, Obstructive Airways Disorder

Drug(s) suspected as cause:
Torsemide
    Dosage: 20 meq/kg, qd
    Administration route: Oral
    Start date: 2011-10-31

Bisoprolol Fumarate
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Start date: 2011-10-31

Spironolactone
    Dosage: 25 mg, qd
    Administration route: Oral
    Start date: 2011-10-31

Omeprazole
    Dosage: 20 mg, qd
    Administration route: Oral
    Start date: 2011-10-31

Metformin
    Dosage: 2000 mg, qd
    Administration route: Oral
    Start date: 2011-10-31

Rasilez
    Dosage: 300 mg, qd
    Administration route: Oral

Other drugs received by patient: Oral Antidiabetics



Possible Spironolactone side effects in female

Reported by a physician from Germany on 2012-02-08

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Uterine Cancer, Dyspnoea, Diabetes Mellitus, Nausea, Flatulence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rasilez HCT
    Dosage: 1 df
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-04

Esomeprazole
    Dosage: 20 mg/day
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2010-11-09

Amlodipine
    Dosage: 10 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-17

Inuvair
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-01-01

Spironolactone
    Dosage: 50 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-09

Other drugs received by patient: Levothyroxine Sodium; Aspirin; Allopurinol



Possible Spironolactone side effects in female

Reported by a physician from Germany on 2012-02-07

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Uterine Cancer, Dyspnoea, Diabetes Mellitus, Nausea, Flatulence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Esomeprazole Sodium
    Dosage: 20 mg/day
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2010-11-09

Inuvair
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-01-01

Spironolactone
    Dosage: 50 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-09

Amlodipine
    Dosage: 10 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-17

Rasilez HCT
    Dosage: 1 df
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-04

Other drugs received by patient: Allopurinol; Levothyroxine Sodium; Aspirin



Possible Spironolactone side effects in 74 year old female

Reported by a physician from Germany on 2012-01-23

Patient: 74 year old female, weighing 80.0 kg (176.0 pounds)

Reactions: Uterine Cancer, Dyspnoea, Diabetes Mellitus, Nausea, Flatulence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-17

Inuvair
    Dosage: 100/6 ug daily
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-01-01

Rasilez HCT
    Dosage: 300/12.5 mg daily
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-04

Esomeprazole
    Administration route: Oral
    Start date: 2010-11-09

Spironolactone
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-09

Other drugs received by patient: Levothyroxine Sodium; Allopurinol; ACE Inhibitor; Aspirin



Possible Spironolactone side effects in 72 year old female

Reported by a physician from Germany on 2012-01-19

Patient: 72 year old female, weighing 80.0 kg (176.0 pounds)

Reactions: Uterine Cancer, Dyspnoea, Diabetes Mellitus, Nausea, Flatulence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-09

Amlodipine Besylate
    Dosage: 10 mg,/day;
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-17

Esomeprazole
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2010-11-09

Aliskiren / Hydrochlorothiazide
    Dosage: 300/12.5mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-04

Inuvair
    Dosage: 100/6 ug/day; regimen 1
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-01-01

Other drugs received by patient: Allopurinol; Levothyroxine Sodium; Aspirin



Possible Spironolactone side effects in female

Reported by a physician from Germany on 2012-01-05

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Uterine Cancer, Dyspnoea, Nausea, Diabetes Mellitus, Flatulence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Esomeprazole Sodium
    Dosage: 20 mg/day
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2010-11-09

Amlodipine
    Dosage: 10 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-17

Spironolactone
    Dosage: 50 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-09

Rasilez HCT
    Dosage: 1 df
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-04

Inuvair
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-01-01

Other drugs received by patient: Levothyroxine Sodium; Aspirin; Allopurinol



Possible Spironolactone side effects in female

Reported by a physician from Germany on 2012-01-05

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Uterine Cancer, Dyspnoea, Diabetes Mellitus, Nausea, Flatulence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rasilez HCT
    Dosage: 1 df
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-04

Esomeprazole Sodium
    Dosage: 20 mg/day
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2010-11-09

Inuvair
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-01-01

Amlodipine
    Dosage: 10 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-17

Spironolactone
    Dosage: 50 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-09

Other drugs received by patient: Aspirin; Levothyroxine Sodium; Allopurinol



Possible Spironolactone side effects in female

Reported by a physician from Germany on 2012-01-05

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Uterine Cancer, Dyspnoea, Diabetes Mellitus, Nausea, Flatulence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Spironolactone
    Dosage: 50 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-09

Inuvair
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-01-01

Amlodipine
    Dosage: 10 mg/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-17

Rasilez HCT
    Dosage: 1 df
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-04

Esomeprazole Sodium
    Dosage: 20 mg/day
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2010-11-09

Other drugs received by patient: Aspirin; Levothyroxine Sodium; Allopurinol



Possible Spironolactone side effects in female

Reported by a physician from Germany on 2011-12-28

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Uterine Cancer, Dyspnoea, Diabetes Mellitus, Nausea, Flatulence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aspirin
    Dosage: 100 mg
    Administration route: Oral
    Indication: Arteriosclerosis Coronary Artery
    Start date: 2007-01-01

Rasilez HCT
    Dosage: 1 df
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-04

Levothyroxine Sodium
    Dosage: 100 ug/day
    Administration route: Oral
    Indication: Thyroid Disorder
    Start date: 2007-01-01

Allopurinol
    Dosage: 100 mg
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2007-01-01

Amlodipine
    Dosage: 10 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-17

Esomeprazole
    Dosage: 20 mg
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease

Spironolactone
    Dosage: 50 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-09

Inuvair
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-01-01



Possible Spironolactone side effects in female

Reported by a physician from Germany on 2011-12-28

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Uterine Cancer, Dyspnoea, Nausea, Diabetes Mellitus, Flatulence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine
    Dosage: 10 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-17

Levothyroxine Sodium
    Dosage: 100 ug/day
    Administration route: Oral
    Indication: Thyroid Disorder
    Start date: 2007-01-01

Rasilez HCT
    Dosage: 1 df
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-04

Spironolactone
    Dosage: 50 mg
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-09

Inuvair
    Indication: Chronic Obstructive Pulmonary Disease
    Start date: 2007-01-01

Allopurinol
    Dosage: 100 mg
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2007-01-01

Esomeprazole
    Dosage: 20 mg
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease

Aspirin
    Dosage: 100 mg
    Administration route: Oral
    Indication: Arteriosclerosis Coronary Artery
    Start date: 2007-01-01



Possible Spironolactone side effects in male

Reported by a physician from United States on 2011-12-12

Patient: male

Reactions: Flushing, Dyspnoea, Swelling Face, Contusion, Headache, Erythema, Facial Pain, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ambrisentan
    Indication: Anaemia

Ambrisentan
    Indication: Renal Failure Chronic

Ambrisentan
    Indication: Malnutrition

Spironolactone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-10-04

Ambrisentan
    Indication: Fluid Overload

Ambrisentan
    Dosage: unk
    Administration route: Oral
    Indication: Pulmonary Hypertension
    Start date: 2011-10-02
    End date: 2011-10-06

Other drugs received by patient: Lactulose; Thiamine; Propranolol; Sildenafil; Klor-CON; Omeprazole; Rifaximin; Ascorbic Acid



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017